节点文献
多重耐药鲍氏不动杆菌医院感染目标性调查及耐药性分析
Objective Investigation and Drug-resistance Analysis of Nosocomial Infections with Multidrug-Resistant Acinetobacter Baumannii
【Author】 YANG Chun-ling~*,SONG Ping,ZHOU Chun-Neng,JIANG Du-Ping (* Yantai shan Hospital,Yantai,Shandong 264008,china)
【机构】 烟台市烟台山医院医院感染管理科; 烟台市传染病医院医院感染管理科;
【摘要】 <正>目的了解多重耐药鲍氏不动杆菌医院感染相关因素及其耐药特性。方法对我院2008年1月22日—2010年12月28日期间63例多重耐药和全耐药鲍氏不动杆菌感染病例采用前瞻性和回顾性调查方法进行综合性分析。结果多重耐药鲍氏不动杆菌感染患者中,36.5%为肺部感染合并多种基础性疾病,42.9%为多发性
【Abstract】 OBJECTIVE To investigate the correlative factors and drug-resistance of nosocomial infections with Multidrug-Resistant Acinetobacter baumannii. METHODS Using the way of forward-looking and reviewing to do Comprehensive analysis for the case of Multidrug-Resistant Acinetobacter baumannii and full drug-Resistant Acinetobacter baumannii happened in our hospital druing 22nd Jan,2008 to 28th Dec,2010. RESULTS Among the infection sufferers of Multidrus-Resistant Acinetobacter baumannii,pulmonary infection combining multi-basic diseases occupied 36.5%,recurring traumatic fracture occupied 42.9%, being hospitalized in ICU occupied 73%,63%undergone surgery,there are 38.1-54%making all kinds of invasive operation with mixed bacterial infection occupied 69.9%.The infection rate of hospital is 60.3% and the total death rate is 31.7%,the death rate incurred by pulmonary infection is up to 71.4%.The acinetobacter baumannii with high drug-resistance rate is imipenem(31.7%),sulperazono sulbactew(37.1%), and other antibacterial(78.4-100%). CONCLUSIONS Strengthen all-directional prevention and control to nosocomial infections with Multidrug-Resistant Acinetobacter baumannii especially to monitor ICU is urgently needed.
- 【会议录名称】 中国医院协会第十八届全国医院感染管理学术年会论文资料汇编
- 【会议名称】中国医院协会第十八届全国医院感染管理学术年会
- 【会议时间】2011-09-17
- 【会议地点】中国北京
- 【分类号】R446.5
- 【主办单位】中国医院协会医院感染管理专业委员会(The Hospital Infection Management Committee,CHA)